3 hours Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly’s ZepboundInvestor's Business Daily
Amgen stock crashed Tuesday after its weight-loss drug met Wall Street’s expectations, but was only on par with Eli Lilly’s Zepbound.
The post Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound appeared first on Investor's B…
Amgen (AMGN) · Business · Eli Lilly (LLY) · Wall Street
X